TRI NGUYEN: Open Payments
NPI 1427155829 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,603 in 117 payments from 29 companies in 2025. Trend: 2023 $2,434 · 2024 $2,876 · 2025 $2,603
Food & beverage: $2,603
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $263 |
| Cleerly, Inc. | 3 | $239 |
| Amgen Inc. | 14 | $207 |
| Novo Nordisk Inc | 12 | $186 |
| AstraZeneca Pharmaceuticals LP | 3 | $168 |
| ViiV Healthcare Company | 6 | $155 |
| Axsome Therapeutics, Inc. | 7 | $155 |
| ABBVIE INC. | 9 | $148 |
| Otsuka America Pharmaceutical, Inc. | 8 | $146 |
| ABIOMED | 3 | $113 |
Products named: Cleerly Ischemia, ELIQUIS, APRETUDE, REXULTI, AIRSUPRA, Auvelity, EVENITY, Wegovy.
Industry payments across TX — which companies pay providers there.
